Viewing Study NCT01503502


Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2026-03-04 @ 10:43 PM
Study NCT ID: NCT01503502
Status: UNKNOWN
Last Update Posted: 2013-04-10
First Post: 2012-01-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous Leukemia
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module